The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse

Developmental Biology

Volumn 328, Issue 1, 2009, Pages 127-139

  Fernandez Valdivia, Rodrigo ^a   Mukherjee, Atish ^a   Ying, Yan ^a   Li, Jie ^a   Paquet, Marilene ^b   DeMayo, Francesco J ^a   Lydon, John P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Mammary gland; Morphogenesis; Progesterone receptor; Prolactin; Receptor Activator of Nuclear Factor B Ligand (RANKL); Salivary gland; Transgenic; Tumorigenesis

Indexed keywords

CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROGESTERONE; PROLACTIN;

ARTICLE; BRANCHING MORPHOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; BREAST HYPERPLASIA; BREAST TUMOR; CELL PROLIFERATION; FIRST TRIMESTER PREGNANCY; MAMMARY GLAND; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; TRANSGENIC MOUSE; TRANSGENICS;

ANIMALIA; MURINAE;

EID: 61349178831     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2009.01.019     Document Type: Article

References (44)

1. Blair J.M., Zhou H., Seibel M.J., and Dunstan C.R. Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat. Clin. Pract. Oncol. 3 (2006) 41-49
2. Brantley D.M., Chen C.L., Muraoka R.S., Bushdid P.B., Bradberry J.L., Kittrell F., Medina D., Matrisian L.M., Kerr L.D., and Yull F.E. Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol. Biol. Cell 12 (2001) 1445-1455
3. Brisken C., Kaur S., Chavarria T.E., Binart N., Sutherland R.L., Weinberg R.A., Kelly P.A., and Ormandy C.J. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev. Biol. 210 (1999) 96-106
4. Brisken C., Heineman A., Chavarria T., Elenbaas B., Tan J., Dey S.K., McMahon J.A., McMahon A.P., and Weinberg R.A. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 14 (2000) 650-654
5. Brisken C., Ayyannan A., Nguyen C., Heineman A., Reinhardt F., Tan J., Dey S.K., Dotto G.P., Weinberg R.A., and Jan T. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev. Cell 3 (2002) 877-887
6. Cao Y., Bonizzi G., Seagroves T.N., Greten F.R., Johnson R., Schmidt E.V., and Karin M. IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107 (2001) 763-775
7. Chen G., Sircar K., Aprikian A., Potti A., Goltzman D., and Rabbani S.A. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 107 (2006) 289-298
8. Clarke R.B., Howell A., Potten C.S., and Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57 (1997) 4987-4991
9. Dougall W.C., and Chaisson M. The RANK/RANKL/OPG triad in cancer-induced bone diseases. Cancer Metastasis Rev. 25 (2006) 541-549
10. Farrugia A.N., Atkins G.J., To L.B., Pan B., Horvath N., Kostakis P., Findlay D.M., Bardy P., and Zannettino A.C. Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo. Cancer Res. 63 (2003) 5438-5445
11. Fata J.E., Kong Y.Y., Li J., Sasaki T., Irie-Sasaki J., Moorehead R.A., Elliott R., Scully S., Voura E.B., Lacey D.L., Boyle W.J., Khokha R., and Penninger J.M. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103 (2000) 41-50
12. Fernandez-Valdivia R., Mukherjee A., Mulac-Jericevic B., Conneely O.M., DeMayo F.J., Amato P., and Lydon J.P. Revealing progesterone's role in uterine and mammary gland biology: insights from the mouse. Semin. Reprod. Med. 23 (2005) 22-37
13. Fernandez-Valdivia R., Mukherjee A., Creighton C.J., Buser A.C., Demayo F.J., Edwards D.P., and Lydon J.P. Transcriptional response of the murine mammary gland to acute progesterone exposure. Endocrinology 149 (2008) 6236-6250
14. Gonzalez-Suarez E., Branstetter D., Armstrong A., Dinh H., Blumberg H., and Dougall W.C. RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini. Mol. Cell. Biol. 27 (2007) 1442-1454
15. Hansen M.F., Nellissery M.J., and Bhatia P. Common mechanisms of osteosarcoma and Paget's disease. J. Bone Miner. Res. 14 Suppl 2 (1999) 39-44
16. Harris J., Stanford P.M., Sutherland K., Oakes S.R., Naylor M.J., Robertson F.G., Blazek K.D., Kazlauskas M., Hilton H.N., Wittlin S., Alexander W.S., Lindeman G.J., Visvader J.E., and Ormandy C.J. Socs2 and elf5 mediate prolactin-induced mammary gland development. Mol. Endocrinol. 20 (2006) 1177-1187
17. Hiremath M., Lydon J.P., and Cowin P. The pattern of beta-catenin responsiveness within the mammary gland is regulated by progesterone receptor. Development 134 (2007) 3703-3712
18. Horseman N.D., Zhao W., Montecino-Rodriguez E., Tanaka M., Nakashima K., Engle S.J., Smith F., Markoff E., and Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16 (1997) 6926-6935
19. Ismail P.M., Li J., DeMayo F.J., O'Malley B.W., and Lydon J.P. A novel lacZ reporter mouse reveals complex regulation of the progesterone receptor promoter during mammary gland development. Mol. Endocrinol. 16 (2002) 2475-2489
20. Ismail P.M., DeMayo F.J., Amato P., and Lydon J.P. Progesterone induction of calcitonin expression in the murine mammary gland. J. Endocrinol. 180 (2004) 287-295
21. Jones D.H., Nakashima T., Sanchez O.H., Kozieradzki I., Komarova S.V., Sarosi I., Morony S., Rubin E., Sarao R., Hojilla C.V., Komnenovic V., Kong Y.Y., Schreiber M., Dixon S.J., Sims S.M., Khokha R., Wada T., and Penninger J.M. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440 (2006) 692-696
22. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5055
23. Kim H.J., Yoon M.J., Lee J., Penninger J.M., and Kong Y.Y. Osteoprotegerin ligand induces beta-casein gene expression through the transcription factor CCAAT/enhancer-binding protein beta. J. Biol. Chem. 277 (2002) 5339-5344
24. Kim N.S., Kim H.J., Koo B.K., Kwon M.C., Kim Y.W., Cho Y., Yokota Y., Penninger J.M., and Kong Y.Y. Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2. Mol. Cell. Biol. 26 (2006) 1002-1013
25. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery Jr. C.A., Shyamala G., Conneely O.M., and O'Malley B.W. Mice lacking progesterone receptors exhibit pleiotropic reproductive abnormalities. Genes Dev. 9 (1995) 2266-2278
26. Lydon J.P., Ge G., Kittrell F.S., Medina D., and O'Malley B.W. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 59 (1999) 4276-4284
27. Ma Z.Q., Chua S.S., DeMayo F.J., and Tsai S.Y. Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B. Oncogene 18 (1999) 4564-4576
28. Maruyama K., Takada Y., Ray N., Kishimoto Y., Penninger J.M., Yasuda H., and Matsuo K. Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice. J. Immunol. 177 (2006) 3799-3805
29. Moraes R.C., Zhang X., Harrington N., Fung J.Y., Wu M.F., Hilsenbeck S.G., Allred D.C., and Lewis M.T. Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia. Development 134 (2007) 1231-1242
30. Mukherjee A., Soyal S.M., Fernandez-Valdivia R., Gehin M., Chambon P., DeMayo F.J., Lydon J.P., and O'Malley B.W. Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse. Mol. Cell. Biol. 26 (2006) 6571-6583
31. Mukherjee A., Soyal S.M., Fernandez-Valdivia R., DeMayo F.J., and Lydon J.P. Targeting reverse tetracycline-dependent transactivator to murine mammary epithelial cells that express the progesterone receptor. Genesis 45 (2007) 639-646
32. Mulac-Jericevic B., Lydon J.P., DeMayo F.J., and Conneely O.M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9744-9749
33. Naylor M.J., Oakes S.R., Gardiner-Garden M., Harris J., Blazek K., Ho T.W., Li F.C., Wynick D., Walker A.M., and Ormandy C.J. Transcriptional changes underlying the secretory activation phase of mammary gland development. Mol. Endocrinol. 19 (2005) 1868-1883
34. Oakes S.R., Rogers R.L., Naylor M.J., and Ormandy C.J. Prolactin regulation of mammary gland development. J. Mammary Gland Biol. Neoplasia 13 (2008) 13-28
35. Poole A.J., Li Y., Kim Y., Lin S.C., Lee W.H., and Lee E.Y. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 314 (2006) 1467-1470
36. Said T.K., Conneely O.M., Medina D., O'Malley B.W., and Lydon J.P. Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo. Endocrinology 138 (1997) 3933-3939
37. Satoh K., Hovey R.C., Malewski T., Warri A., Goldhar A.S., Ginsburg E., Saito K., Lydon J.P., and Vonderhaar B.K. Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2. Oncogene 26 (2007) 7526-7534
38. Shyamala G., Yang X., Silberstein G., Barcellos-Hoff M.H., and Dale E. Transgenic mice carrying an imbalance in the native-ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 696-701
39. Shyamala G., Yang X., Cardiff R.D., and Dale E. Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3044-3049
40. Srivastava S., Matsuda M., Hou Z., Bailey J.P., Kitazawa R., Herbst M.P., and Horseman N.D. Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells. J. Biol. Chem. 278 (2003) 46171-46178
41. Theill L.E., Boyle W.J., and Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20 (2002) 795-823
42. Tucker A.S. Salivary gland development. Semin. Cell Dev. Biol. 18 (2007) 237-244
43. Walsh M.C., and Choi Y. Biology of the TRANCE axis. Cytokine Growth Factor Rev. 14 (2003) 251-263
44. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., and Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 (1994) 669-671